STRATEC BIOMEDICAL SYSTEMS AG : Hauck & Aufhauser remains Neutral -April 03, 2024 at 05:22 am EDT

Hauck & Aufhauser's research confirms his advice and maintains his neutral opinion on the stock. The target price is unchanged at EUR 40.

Related Keywords

Hauck Aufhauser , ,Markets ,